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Background: One of the hallmarks of retroviral life cycle is the efficient and specific packaging of two copies of
retroviral gRNA in the form of a non-covalent RNA dimer by the assembling virions. It is becoming increasingly clear
that the process of dimerization is closely linked with gRNA packaging, and in some retroviruses, the latter depends
on the former. Earlier mutational analysis of the 5’ end of the MMTV genome indicated that MMTV gRNA packaging
determinants comprise sequences both within the 5’ untranslated region (5’ UTR) and the beginning of gag.
Results: The RNA secondary structure of MMTV gRNA packaging sequences was elucidated employing selective
2’hydroxyl acylation analyzed by primer extension (SHAPE). SHAPE analyses revealed the presence of a U5/Gag
long-range interaction (U5/Gag LRI), not predicted by minimum free-energy structure predictions that potentially
stabilizes the global structure of this region. Structure conservation along with base-pair covariations between
different strains of MMTV further supported the SHAPE-validated model. The 5’ region of the MMTV gRNA contains
multiple palindromic (pal) sequences that could initiate intermolecular interaction during RNA dimerization. In vitro
RNA dimerization, SHAPE analysis, and structure prediction approaches on a series of pal mutants revealed that
MMTV RNA utilizes a palindromic point of contact to initiate intermolecular interactions between two gRNAs,
leading to dimerization. This contact point resides within pal II (5’ CGGCCG 3’) at the 5’ UTR and contains a
canonical “GC” dyad and therefore likely constitutes the MMTV RNA dimerization initiation site (DIS). Further analyses
of these pal mutants employing in vivo genetic approaches indicate that pal II, as well as pal sequences located in
the primer binding site (PBS) are both required for efficient MMTV gRNA packaging.
Conclusions: Employing structural prediction, biochemical, and genetic approaches, we show that pal II functions
as a primary point of contact between two MMTV RNAs, leading to gRNA dimerization and its subsequent
encapsidation into the assembling virus particles. The results presented here enhance our understanding of the
MMTV gRNA dimerization and packaging processes and the role of structural motifs with respect to RNA-RNA and
possibly RNA-protein interactions that might be taking place during MMTV life cycle.
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An essential step in retroviral life cycle is the efficient
and specific packaging of two copies of plus-strand full-
length genomic RNA (gRNA) into the virus particle
from a large pool of cellular and other viral RNAs in the
cytoplasm (reviewed in [1-6]). Retroviral RNA packaging
process involves the recognition of cis-acting packaging
signal(s) by the zinc finger(s) in the nucleocapsid (NC)
domain of the Gag polyprotein (reviewed in [1-4,7]).
Over the years, it has been shown that the packaging sig-
nal(s) of different retroviruses reside at the 5’ end of the
gRNA and include continuous or discontinuous sequences
from R, U5, and 5′ untranslated (UTR) regions and extend
into the 5’ end of the gag gene (reviewed in [1-3,8-10]).
The retroviral RNA genome is packaged as a non-
covalent dimer and the processes of dimerization and
packaging are closely interlinked (reviewed in [1-6,11]).
The sequences responsible for retroviral gRNA pack-
aging and dimerization of a variety of retroviruses map
to the same ~100-400 nucleotides (nt) at the 5’ end of
the gRNA, and in most cases are genetically indistin-
guishable (reviewed in [1-3]).
Recent retroviral RNA cross-packaging studies have
shown that the specificity of retroviral gRNA packaging
can be exchanged by substituting the packaging signals
of genetically diverse retroviruses [12,13]. This has fur-
ther been substantiated by the fact that heterodimers in-
volving RNAs from two divergent retroviruses with no
sequence homology can also be packaged (reviewed in
[2,11,14]). In addition, a number of RNA cross- and co-
packaging studies among diverse retroviruses suggest
that the process of gRNA dimerization and packaging is
likely to involve recognition of structural motifs rather
than primary sequences [12,13,15-19]. Consistent with
this, the packaging and dimerization sequences of almost
all retroviruses have been shown to assume higher order
structures comprising of various structural motifs that
have been shown to mediate RNA-RNA and RNA-protein
interactions during retroviral RNA dimerization and pack-
aging (reviewed in [1-4,20].
Retroviral RNA dimerization is usually mediated by a
palindromic (pal) sequence known as the dimerization ini-
tiation site (DIS) present in the 5’ region of the gRNA. In
a number of retroviruses, the DIS has been shown to as-
sume a hairpin structure containing a canonical “GC”
dyad which interacts with the DIS loop on the second
gRNA copy, resulting in a kissing loop interaction [21-26];
(further reviewed in [27]). Pal sequences involved in RNA
dimerization have been identified in human and simian
immunodeficiency viruses (HIV-1, HIV-2, and SIV)
(reviewed in [5,6,25,28-32]), feline immunodeficiency virus
(FIV) [23,33], Mason-Pfizer monkey virus (MPMV) [8,21],
and avian leukosis virus (ALV) [34]. In addition to gRNA
dimerization and packaging, mutations in the DIS havebeen shown to affect other steps in retroviral life cycle
such as reverse transcription [25,29,32,35,36] and recom-
bination [37-39]. Since the DIS has been shown to regulate
the retroviral life cycle, it is therefore an attractive target
for antiretroviral drugs, such as aminoglycosides [40,41].
Despite having been studied extensively, little is known
about the molecular mechanisms of gRNA dimerization
and packaging during the mouse mammary tumor virus
(MMTV) life cycle [42,43]. An earlier study by Salmons
et al., [44] suggested that MMTV harbors sequences re-
sponsible for gRNA packaging in the 5’ region of its gen-
ome. Employing a biologically relevant in vivo packaging
and transduction assay for MMTV [45], we have recently
identified a continuous region, spanning the beginning of
R to 120 nt of gag that was found to be critical for MMTV
gRNA packaging and propagation [10]. Folding algorithms
predicted that these sequences fold into a higher order
structure comprising of a number of stable structural
motifs.
In this study, we employed the technique of selective
2’hydroxyl acylation analyzed by primer extension (SHAPE)
[46-48] to validate and further refine the predicted higher
order features of the MMTV packaging signal. The
SHAPE-validated RNA secondary structure revealed four
prominent pal sequences (pal I, pal II, primer binding site
(PBS) pal, and pal III), and one or more of them could po-
tentially be involved in initiating intermolecular inter-
actions during MMTV gRNA dimerization. A systematic
deletion/substitution analysis of different pal mutants
using in vitro dimerization, in vivo packaging and trans-
duction assays revealed that RNA dimerization, packaging
and propagation processes of pal II mutants was greatly
compromised. Results obtained from these complemen-
tary approaches indicate that pal II serves as the primary
palindromic point of contact during intermolecular inter-
actions, leading to the dimerization and RNA packaging
processes during MMTV life cycle.
Results
Predicted secondary structure of the MMTV 5’ gRNA
Using MMTV transfer vectors containing sequences from
the 5’ end of the genome revealed that the sequences ne-
cessary for optimal MMTV gRNA packaging start at R
and extend into first 120 nt of gag [10]. Therefore, the
RNA secondary structure of the 5’ region of the MMTV
gRNA containing 120 nt of gag (432 nt of the 5’ end from
R) was predicted using Mfold. Specifically, structural ana-
lysis of this region predicted six stem loops 1-6 (SLs1-6,
Figure 1A). Briefly, two stable stem loops, SL1 and SL2,
were predicted in the R/U5/PBS/UTR region in addition
to SL5 and SL6 in the gag region (Figure 1A). In between
these stem loops, SL3 and a bifurcated SL4 were predicted
in the UTR region. SL2 was found stably maintained in all
predicted structures (data not shown). A closer look at the
Figure 1 Predicted and SHAPE-validated structural models of the MMTV packaging signal RNA. (A) MMTV packaging signal RNA
secondary structure predicted using Mfold. mSD, major splice donor, PBS, primer binding site. (B) Schematic representation of full length MMTV
genome, showing the region used to create the T7 expression plasmid, SA035. (C) SHAPE-constrained RNA structure model of MMTV packaging
signal. Nucleotides are color annotated as per the SHAPE reactivities key depending on their modification by BzCN. The data shown is an average
of 3-6 independent experiments.
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quences, a 10 nt pal I in SL2, a pal sequence in PBS la-
belled as PBS pal, a 6 nt pal II in bifurcated SL4, and a
13 nt pal III in SL6 (Figure 1A). The PBS pal contained
two overlapping pals (5’ CAGCUGGCGCC 3’; the first pal
is in italics and the second pal is in bold letters (Figure 1A).
Additionally, a 9 nt stretch of single-stranded purines
(ssPurines) was also observed in SL4 which have been sug-
gested to play a role in RNA-protein interaction during
gRNA packaging [11,26]. The first apical loop of the bifur-
cated SL4 comprised pal II, while the second apical loop
contained the ssPurines (Figure 1A).
Validation of the secondary structure by SHAPE
To experimentally validate the predicted structure of the
MMTV packaging signal RNA, we employed the SHAPEmethodology [46-48]. Since ~50 nt at the 3’ end of the
RNA molecule is lost due to primer binding for cDNA
synthesis; therefore, to ensure that the entire 432 nt region
of the 5’ end of the MMTV genome could be properly an-
alyzed by SHAPE, we cloned a larger piece of RNA upto
712 nt in the wild type clone (SA035; Figure 1B) for in vitro
transcription. Briefly, RNA transcribed from SA035 was
purified, incubated in the dimer buffer, and modified with
BzCN, as described earlier [21]. BzCN selectively acylates
the 2’ hydroxyl group of ribose within nucleotides in fle-
xible (unpaired) regions. Reactivity at each nucleotide was
calculated by subtraction of the reverse transcription
product of unmodified RNA from that of BzCN-modified
RNA [21,49]. The SHAPE reactivity data obtained for each
nucleotide from 3-6 independent experiments were then
applied as pseudo-energy constraints in the structure
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refined RNA structural model of the sequences required
for MMTV gRNA dimerization and packaging.
Consistent with the predicted structure, most of the
loops and bulges containing unpaired nucleotides in the
MMTV packaging signal RNA showed SHAPE reactivity
(Figure 1C). We also observed moderate and high reac-
tivities of nucleotides forming G-U base pairs, especially
at the end of helices (G120, U320, G193, U294, G324,
U356, U357, U358, U415, Figure 1C). Some base paired
nucleotides (G21, C25, G84) located on either side of a
bulge or loop also showed certain amount of reactivity,
as expected. The refined structural model corroborated
well with the predicted structure, supporting the exis-
tence of major structural motifs (SL1-SL6; Figure 1C).
SHAPE also confirmed the existence of the bifurcated
SL4 structure containing the 9 nt stretch of ssPurines
and pal II, as predicted by Mfold (Figure 1C).
Even though a high conformity was observed between
the predicted and the SHAPE-validated structural models,
some conspicuous dissimilarity could be noted. In the
SHAPE validated structure, SL1 and SL6 were shorter,
resulting in the formation of SL7 which was not ob-
served in the predicted structure (compare Figure 1A with
Figure 1C). In addition, the sequences 5’ to the shortened
SL6 form a new stem loop which is different from the pre-
dicted SL5 (Figure 1A) and therefore was labeled as SL5’
(Figure 1C). Interestingly, the single-stranded bulges and
loops in and around SL3 did not show significant SHAPE
reactivity despite being unpaired in the secondary struc-
ture model. This could possibly suggest that these nuc-
leotides are involved in tertiary or inter/intramolecular
interactions. Furthermore, the SHAPE-validated structure
harbored a long-range interaction (LRI) involving comple-
mentary sequences from U5 and Gag (U5/Gag LRI) which
was not predicted by Mfold (compare Figure 1A with
Figure 1C). This U5/Gag LRI is made up of three
short helices separated by a bulge and an internal loop
(Figure 1C).
The SHAPE-validated RNA structural model is supported
by phylogeny
Sequence alignment of eight strains of MMTV (sequence
from +1R-120 nt gag) revealed a high degree of conserva-
tion relative to the wild type mtv-1 (AF228550.1) strain,
especially of sequences of the major structural motifs such
as U5/Gag LRI, ssPurines, pal II, and PBS pal (Additional
file 1A) once superimposed on the SHAPE-validated
structure (Additional file 1B). Only a small number of
nucleotides were observed to be variable (<75% conserva-
tion as shown in Additional file 1B). Finally, we generated
a consensus structure of this region using RNAalifold
(Additional file 2). Consistent with the SHAPE-validated
structure (Figure 1C), consensus RNA secondary structurepredictions (Additional file 2) revealed that the major
structural motifs were consistently maintained. In addi-
tion, the consensus structures predicted by RNAalifold
also supported the existence of SHAPE-validated short
SL6 and SL5’ over the Mfold predicted long SL6 and SL5
motifs (compare Figure 1A, Figure 1C, and Additional
file 2). The consensus structures also revealed the exis-
tence of LRI which is very similar to the one observed in
the SHAPE-validated structure (Figure 1C and Additional
file 2).Identification of the pal sequence mediating MMTV gRNA
dimerization and packaging
The SHAPE-validated region found to be crucial for
MMTV gRNA packaging revealed four pal sequences
(Figure 1C) which could possibly play role(s) in intermo-
lecular RNA interaction(s) to augment dimerization and
subsequent packaging of the dimerized genome. There-
fore, to ascertain which pal may mediate such inter-
actions, we performed a systematic mutational analysis
of these pal sequences and tested their effects on both
RNA dimerization and packaging employing a combi-
nation of genetic and biochemical approaches.Mutational analysis of pal I reveals that it does not play a
role in MMTV gRNA dimerization and packaging
The mutations introduced in pal I are shown in Figure 2A.
These mutations included a complete deletion of 26 nt of
the apical stem loop of SL2 containing pal I, as well as
simultaneous substitution of the deleted sequences with a
UUCG stable tetraloop in order to maintain a stem loop
structure without pal I [21]. It is important to mention
that the attachment (att) sites needed for integration of
the provirus were not affected in pal I mutants, thus
allowing us to test the same mutations in both the in vitro
dimerization as well as in vivo packaging and propagation
assays [45]. As RNA dimers may have different stabilities,
we analysed the RNA dimers by agarose gel electropho-
resis in the presence of either TB or TBM buffers. The
presence of Mg2+ ions minimizes dissociation of RNA
dimers during electrophoresis, while weak dimers might
dissociate during electrophoresis in TB buffer [34,50].
None of the deletion and/or deletion/substitution mutants
showed any detrimental effects on dimerization when
compared to the wild type clone SA035 (Figure 2B). The
fold dimerization of the mutant clones (SA031-SA033)
was observed to be between 0.88-1.04 in TBM gels and
1.29-1.82 in TB gels compared to the wild type, SA035
clone (data not shown). The increased amounts of dimers
in the TB gels might reflect a stabilization of the mutant
RNA dimeric species. Altogether, these data indicate that
pal I does not play a major role in initiating intermolecular
interactions between the two gRNAs.
Figure 2 Role of pal I in MMTV gRNA dimerization, packaging, and propagation. (A) Description of the pal I mutants. The wild type pal I
sequence is shown in blue and the mutations are depicted in red. (B) Typical RNA dimerization TBM and TB gels of wild type and mutant MMTV
RNAs. M: monomer lane or monomer conformer; D: dimer lane or dimer conformer for each sample. (C) Transfection efficiencies of the mutants
and wild type transfer vectors that were used to normalize the packaging efficiency. LUC: Luciferase activity. (D) PCR amplifications of the DNase
treated cytoplasmic (panel i) and viral (panel ii) RNAs using virus specific primers. In the third panel (iii), amplification was conducted on the
cDNAs obtained from cytoplasmic RNAs using primers that amplify unspliced β-actin mRNA. Multiplex amplifications were conducted in the
presence of primers/competimer for 18S ribosomal RNA. The fourth panel (iv) shows PCR of cytoplasmic cDNA using primers that amplify spliced
β-actin mRNA. (E) Relative packaging efficiency (RPE) of transfer vector RNAs. (F) Relative hygromycin resistance (Hygr) colony forming unit per ml
(CFU/ml) for mutant transfer vectors reflecting the relative RNA propagation efficiencies. In (C), (E), and (F), the histograms represent data from at
least three independent experiments (± SD). The P values for all mutants in panel (F) were significant (<0.001).
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in pal I, we tested these mutants in a biologically-relevant
in vivo packaging and propagation assay (Additional file 3).
This was accomplished by cloning these mutations into
the MMTV subgenomic transfer vector, DA024, creating
SA031P-SA033P pal I mutant transfer vectors (Figure 2A).
These transfer vectors were tested by transfecting human
embryonic kidney (HEK) 293T cells along with the pack-
aging and vesicular stomatitis virus glycoprotein (VSV-G)
envelope expression constructs (Additional file 3). The
wild type and mutant viral particles produced were used
to: 1) measure the packaged viral RNA using qPCR, and
2) assess the propagation of the packaged RNA in the
target cells which was monitored by the appearance of
hygromycin resistant colonies. We first checked the
transfection efficiency of the cultures containing mutant
transfer vectors. The transfection efficiencies from at
least three independent experiments were observed to be
within 2 folds of each other, suggesting that all cultureswere efficiently transfected (Figure 2C). These transfection
efficiencies were taken into account to normalize and cal-
culate the RNA packaging efficiency and propagation data
for each mutant relative to the wild type.
To determine the RNA packaging efficiency, cDNAs
were prepared from cytoplasmic and pelleted virion
RNAs. Before making the cDNAs these RNAs were sub-
jected to DNase treatment to ensure that there was no
contaminating plasmid DNA, followed by PCR using
virus-specific primers. Following amplification, the lack
of a positive signal indicated that the DNA contamin-
ation in our RNA preparations was below the detection
level (Figure 2D, panels i and ii). After having confirmed
this, RNA preparations were reverse transcribed and
cDNAs were prepared. Since the relative packaging
efficiency data is expressed in relation to the efficiently
and stably expressed viral RNAs that are exported from
the nucleus to the cytoplasm, we monitored the integrity
of the cytoplasmic RNA fraction by checking for the
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panel iii). To ensure that each cytoplasmic RNA fraction
contained amplifiable cDNAs, the unspliced β-actin PCRs
were conducted in the presence of primers/competimer
for 18S ribosomal RNAs as an internal control [8,10,33].
In a separate amplification reaction, the same cytoplasmic
cDNA samples were amplified using spliced β-actin pri-
mers (Figure 2D, panel iv). Figure 2D shows that while
18S ribosomal RNA and spliced β-actin mRNA were
amplifiable, unspliced β-actin mRNA was not. These re-
sults indicated that the fractionation technique employed
was robust and that the nuclear membrane integrity was
maintained during the fractionation process.
In order to monitor the effect of pal I mutants on
gRNA packaging, the relative expression of transfer vec-
tor RNAs in the cytoplasm was tested using a custom-
made MMTV real time PCR assay in combination with
a commercially available-endogenous β-actin Taqman
assay as described earlier [10]. Following normalization
of the RNA packaged into the virus particles to the cyto-
plasmic transfer vector RNA expression and to transfec-
tion efficiencies, the packaging efficiency of the transfer
vector RNAs into the virus particles was measured (see
Methods). The in vivo gRNA packaging data from mul-
tiple experiments revealed that none of the pal I muta-
tions significantly decreased gRNA packaging (P >0.01;
Figure 2E). This corroborated well with the dimerization
data for the same mutants which showed no significant
dimerization defect (Figure 2B). Interestingly, when viral
particles containing RNAs from these mutants were
used to transduce target cells with a hygromycin re-
sistance gene, a drastic reduction of RNA propagation
(6-20 fold reduction of the relative CFU/ml, P ≤0.001)
was observed for all mutants (Figure 2F). Lack of RNA
propagation of the packaged mutant transfer vector
RNAs suggests that the introduced mutations impaired
post packaging events of viral life cycle such as reverse
transcription and/or integration since our readout assay
is dependent on successful completion of these steps.
Consistent with this hypothesis, mutations in close
vicinity of the PBS (as has been the case for these pal I
mutants) have been shown to greatly impinge reverse
transcription [25,51,52].
Mutational analysis of pal II and the PBS pal suggests that
there could be two points of contact between the gRNAs
leading to MMTV gRNA dimerization
To test if pal II modulates MMTV gRNA dimerization
and packaging, we introduced a series of similar muta-
tions, including a complete deletion of pal II as well as
substitution with a stable tetraloop sequence, in order to
maintain the overall RNA secondary structure of this re-
gion (Figure 3A). Data obtained from 2-6 independent
experiments revealed that a complete deletion of pal IIresulted in a significant ~ two-fold decrease in RNA
dimerization, both in TBM and TB gels (Figure 3B and
Figure 3C, compare mutant SA042 with wild type
SA035, P ≤ 0.001). Deletion of pal II with simultaneous
substitution with a stable tetraloop had the same effect
on RNA dimerization (Figure 3B and Figure 3C, mu-
tant SA41; ~ two-fold reduction in relative RNA dime-
rization; P < 0.001).
These results indicated that although pal II deletion mu-
tants could reduce RNA dimerization, they could not
completely abrogate it. Such an observation suggested the
presence of another sequence that could facilitate dime-
rization in addition to pal II, though not to the wild type
levels. Therefore, the pal II deletion mutant (SA042) se-
quence was folded as dimer using the RNAstructure soft-
ware, which predicted that in the absence of pal II, the
MMTV RNA packaging signal could potentially dimerize
via the two overlapping pals in the PBS (5’ CAGCU
GGCGCC 3’; the first pal is in italics and the second pal is
in bold (Figure 4). To determine the role of PBS pal, if
any, on dimerization, a mutant (SA051) was generated
containing a complete deletion of the 11 nt overlapping
pals within the PBS. Along the same lines, a double mu-
tant (SA046) was created containing the deletion of pal II
sequence as well as the overlapping pals within the PBS
(Figure 3A). Deletion of the 11 nt PBS pal alone in SA051
resulted in 60% reduction in RNA dimerization levels
(P ≤0.05; Figure 3B and Figure 3C). Deletion of both se-
quences (SA046) resulted in almost a complete abrogation
of dimerization in TBM condition (18-fold; P <0.002) and
to a 3.5-fold decrease in TB condition (P <0.006; Figure 3B
and Figure 3C). These results suggest that the MMTV
genome may require two points of contact during in-
termolecular interactions to augment efficient gRNA
dimerization.
Results in Figure 3 and Figure 4 showed that one of the
points of contact between the two RNAs is pal II. To as-
certain whether the primary sequence or the palindromic
nature of pal II is important to initiate intermolecular in-
teractions between the two RNAs during MMTV gRNA
dimerization, we generated several additional mutants.
The wild type pal II was substituted with HIV-1 pal
flanked by additional purines (5’ AAGCGCGCA 3’;
Figure 5A, mutant SA047). Two additional mutants were
also created in which the pal II sequence was substituted
by non-palindromic trans-complementary sequences
(Figure 5A, mutants SA044 and SA045). In all of these
mutants, the pal sequence within the PBS was maintained.
Consistent with the effect of the purines flanking the pal
sequence on HIV-1 RNA dimerization [26], replacing pal
II by the HIV-1 pal and the flanking purines (SA047)
preserved MMTV RNA dimerization to wild type levels
(Figure 5B and Figure 5C). The trans-complementary mu-
tants SA044 and SA045 RNAs were incubated either
Figure 3 Role of pal II and PBS pal in MMTV gRNA dimerization, RNA packaging and viral propagation. (A) Description of the pal II
mutants. (B) Typical RNA dimerization in TBM and TB gels of wild type and mutant MMTV RNAs. M: monomer lane or monomer conformer; D: dimer
lane or dimer conformer. (C) Quantification of the relative RNA dimerization levels (see table below the histogram). Table above the histogram
represent the P values of the respective mutants in TBM and TB gels. The experiments were repeated 2-6 times. (D) Relative packaging efficiency of
transfer vector RNAs. (E) RNA propagation efficiency expressed as Hygr colony forming unit per ml (CFU/ml). In (C), (D), and (E), the histograms
represent data from at least three independent experiments (± SD). The P values for all mutants in panels (D) and (E) were significant (<0.001).
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intermolecular interactions due to the trans-complemen-
tary nature of the sequences. When incubated separately,
the mutants displayed a ~ two-fold decrease in dimerization
(P <0.001; Figure 5B and Figure 5C), as expected similar to
other pal II substitution and deletion mutants (Figures 3B
and Figure 3C). Surprisingly, RNA dimerization was not
restored when these trans-complementary mutants were
co-incubated since the level of dimerization observed for
the individual mutants was the same as when the equal
amounts of two mutant RNAs were incubated together
(two-fold decrease in dimerization; P <0.001; Figure 5B
and Figure 5C). This is in sharp contrast with other re-
troviral systems in which dimerization has been restored
to wild type levels in the mutants containing trans-
complementary sequences [21,53-55].Role of pal II and PBS pal in regulating MMTV gRNA
packaging and propagation
Next, we analyzed the RNA packaging and propagation
efficiencies of the pal II and PBS pal mutants by cloning
these mutations into the MMTV subgenomic transfer
vector, DA024, similar for the pal I mutants, creating
SA041P-SA047P and SA051P (Figure 3A and Figure 5A).
Data from several experiments showed that pal II and
PBS pal mutants’ transfection efficiencies were within
two folds and that the transfer vector RNAs were
expressed efficiently (data not shown). When similar
amounts of virions were used to isolate packaged RNA,
all of the mutants tested except for SA051P, were found
to be severely impaired for gRNA packaging (27-150 fold
reduction, P < 0.001, Figure 3D and Figure 5D). Al-
though packaged, the relative packaging efficiency of
Figure 4 Structural analysis of pal II and PBS pal deletion-mutant homodimers. Predicted homodimer structures of (A) MMTV wild type
(SA035), (B) pal II deletion (SA042), (C) deletion of the pal sequence within PBS (SA051) and (D) double deletion of both pal II and pal sequence
within PBS (SA046). The dimers were predicted using RNAstructure and the contact point (point of dimerization) of the sequences between two
RNAs leading to dimerization are boxed.
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wild type (Figure 3D). Interestingly, deletion of either pal
II or the PBS pal had a pronounced effect on RNA pack-
aging (even though the effect of pal II deletion was more
dramatic on packaging; Figure 3), suggesting that the
MMTV Gag precursor initially recognizes an RNA
dimer with two points of contact.
Propagation of these mutants, as measured by counting
the number of hygromycin resistant colonies (CFU/ml) in
the infected cultures correlated well with the significantly-
reduced RNA packaging data (Figure 3E and Figure 5E).
Lack of propagation of SA051P mutant can be explained
despite residual RNA packaging by the deletion in the
PBS, since our assay requires the packaged RNA to be
successfully reverse transcribed (initiated by an intact
PBS) before integration to allow expression of the
hygromycin resistant gene and subsequent appearance of
hygromycin-resistant colonies.Altogether, the dimerization and packaging results sug-
gest that the pal II and PBS pal play important roles in
both MMTV gRNA dimerization and packaging. However,
the case of mutant SA047P containing substitution of pal
II with HIV-1 pal along with flanking purines was intri-
guing as its RNA packaging and propagation were abol-
ished (Figure 5D and Figure 5E), despite displaying wild
type RNA dimerization levels (Figure 5B and Figure 5C).
These results suggest that RNA dimerization may not be
sufficient to ensure RNA packaging and propagation and
further indicate that pal II could also be involved in RNA-
protein interactions during genome encapsidation.
SHAPE analyses of pal II mutants support their role in
MMTV gRNA dimerization
In order to test whether the dimerization, packaging and
propagation data could be explained by the effects
of mutations in pal II and PBS pal on MMTV RNA
Figure 5 Effects of pal II substitution mutations on MMTV gRNA dimerization, RNA packaging and viral propagation. (A) Description of
the pal II substitution mutants. (B) Typical RNA dimerization in TBM and TB gels of wild type and mutant MMTV RNAs. The last two lanes correspond
to the co-incubation of trans-complementary mutants SA044 and SA045. M: monomer lane or monomer conformer; D: dimer lane or dimer conformer.
(C) Quantification of the relative RNA dimerization (see table below the histogram). Table above the histogram represent the P values of the respective
mutants in TBM and TB gels. The experiments were repeated 2-6 times. (D) Relative packaging efficiency of transfer vector RNAs. (E) RNA propagation
efficiency expressed as relative Hygr colony forming unit per ml (CFU/ml). In (C), (D), and (E), the histograms represent data from at least three
independent experiments (± SD). The P values for all mutants in panels (D) and (E) were significant (<0.001).
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these mutants in dimer buffer, as described. Under this
condition, the wild type RNA (SA035) was largely dimeric
when electrophoresis was conducted in TBM buffer, as
can be observed in Figures 2, 3, and 5, thus allowing easy
interpretation of results. Figure 6 focuses on the SL4 re-
gion (~ nt 250-303, encompassing pal II), while Figure 7
on the PBS region, respectively. Overall, no major struc-
tural changes could be observed for any of the mutants
compared to the wild type. Specifically, in the wild type
RNA (SA035) and in the substitution mutant with the
HIV-1 pal containing flanking purines (SA047), the two
pals displayed limited or no SHAPE reactivity (Figure 6A),
consistent with their expected role in RNA dimerization
(Figure 5B and Figure 5C). Accordingly, pal II substitutionmutants with decreased RNA dimerization displayed high
reactivity of at least one nucleotide in the mutated region
(SA041, SA044, SA045, Figure 6A). The ssPurines se-
quence was highly reactive in all RNAs (Figure 6A). Se-
veral mutants (SA041, SA044, and SA047) preserved the
bifurcated stem loop structure of SL4 (Figure 6B). Surpris-
ingly, SA045 containing a substitution of pal II with non-
palindromic sequence adopted a totally different structure
in which the mutated sequence was mostly base-paired
(Figure 6B). Misfolding of this RNA likely explains why
the trans-complementary mutants SA044 and SA045 were
unable to form heterodimers (Figure 5B and Figure 5C).
In the two pal II deletion mutants (SA042 and SA046),
SL4 adopted a single hairpin conformation in which most
of the nucleotides that formed the bifurcating loop in the
Figure 6 (See legend on next page.)
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(See figure on previous page.)
Figure 6 SHAPE and structural analyses of the SL4 domain of the pal II and PBS pal mutants. (A) SHAPE reactivity profile of the wild type
and mutant RNAs. Blue boxes indicate pal II, ssPurines, and deletion/substitutions in pal II. Data are an average of at least three independent
experiments. (B) Predicted structure of the wild type and mutant SL4 domain in the SHAPE-constrained RNA model by RNAstructure (C) The
RNAstructure predicted site of interaction (point of dimerization) between two wild type gRNAs. The central 6 nt of pal II are shown in blue.
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ning the reduction in dimerization observed (Figure 3B
and Figure 3C).
Next we analysed the structure of the SL2 domain, which
contains the PBS pal, in the wild type and mutant RNAs.
Although the PBS is predicted to be unpaired in mono-
meric RNA, the overlapping PBS pals were weakly reactive
(Figure 7A), especially the second pal (5’ GGCGCC 3’),
consistent with their potential role in RNA dimerization by
forming loose dimers. The reactivity of this region was not
significantly affected by deletion or substitutions in pal II
(Figure 7A, mutants SA042 and SA047), suggesting the
second pal within the PBS could potentially play a role in
RNA dimerization (Figure 3B, 3C and Figure 5B, 5C).Figure 7 SHAPE and structural analyses of the SL2 domain of the pal
and mutant RNAs are presented as color-coded histograms. The blue boxe
SHAPE-validated wild type SA035 SL2 domain structure and the nucleotide
SL2 structural motif is shown after being constrained by SHAPE data.Structural prediction of mutant dimers supports
dimerization data
To establish a structural basis of the in vitro dime-
rization results, we predicted minimal free energy
models of the wild type and mutant MMTV RNA di-
mers using RNAstructure. This software predicted that
wild type RNA dimerizes via the pal II sequence
(Figure 4A), while deletion of pal II (SA042) induces
dimerization via the PBS pal (Figure 4B), in agreement
with our RNA dimerization and SHAPE data (Figure 3,
Figure 5, Figure 6, and Figure 7). The predicted structure
of SA051 (deletion of 11 nt pal sequence within PBS),
revealed that the native structure (like wild type homo-
dimer) was restored except for the loss of the PBS loopII and PBS pal mutants. (A) The SHAPE reactivity of the wild type
s highlight the SL2 loop sequences and the 11 nt PBS pal. (B) The
s are color-coded according to SHAPE reactivity. (C) The mutant SA046
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dimerize though much less efficiently when compared to
the wild type (Figure 3B and Figure 3C). The mutant
with simultaneous deletions of pal II and the PBS pal
(SA046) was predicted to dimerize via pal III (Figure 4D),
but according to our experimental data, this mutant
RNA dimerized weakly (Figure 3B and Figure 3C). Taken
together, this data suggests that such intermolecular pre-
dicted interaction utilizing pal III is unlikely to occur
in vivo. Trans complementary substitution mutants with
non-palindromic sequences in place of pal II (SA044
and SA045) were predicted to homodimerize via the
PBS pal (Figure 8A and Figure 8B). Surprisingly and in
good agreement with our experimental data (Figure 5),
these two mutant RNAs were predicted to form hete-
rodimers via the PBS pals rather than via their trans-
complementary mutated sequences (Figure 8C).Figure 8 Structural analysis of pal II trans complementary-mutants. P
II trans-complementary mutants (SA044 and SA045). The dimers were pred
(point of dimerization) between two RNAs leading to dimerization are boxAdditional mutational analysis of pal II, PBS pal, and pal
III confirms the primary role of pal II in MMTV gRNA
dimerization
Results presented in Figure 3 suggested that in addition to
pal II, the PBS pal may also play a role in gRNA
dimerization since its deletion in SA051 affected gRNA
dimerization by ~60%. Structure-prediction analysis fur-
ther revealed that in the absence of pal II, the point of
contact between the two RNAs involved a stretch of palin-
dromic nucleotides (5’ GGCGCC 3’) within the PBS pal.
To analyze the role of these 6 nucleotides in PBS pal in
RNA dimerization, several substitution mutations were
introduced in SA035, the wild type vector (Figure 9A).
SA056 replaced the 6 nucleotides of PBS pal with the
HIV-1 pal and its flanking purines, while mutants SA057-
SA060 replaced the 6 nts PBS pal with non-palindromic
trans complementary sequences containing additionalredicted homodimer (A-B) and heterodimer (C) structures of MMTV pal
icted using RNAstructure and the contact point of the sequences
ed.
Figure 9 Further mutational analysis of PBS pal towards MMTV gRNA dimerization. (A) Description of the PBS pal mutants. (B) Typical
RNA dimerization in TBM and TB gels of wild type and mutant MMTV RNAs. M: monomer lane or monomer conformer; D: dimer lane or dimer
conformer. (C) Quantification of the relative RNA dimerization levels (see table below the histogram). Table above the histogram represent the
P values of the respective mutants in TBM and TB gels. The histograms represent data from at least three independent experiments (± SD).
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SA047 (Figure 5A). Test of these mutants in the in vitro
dimerization assay revealed that none of the mutations af-
fected dimerization significantly (Figure 9B and Figure 9C).
The trans complementary mutants SA057- SA060 abro-
gated the palindromic nature of PBS pal; however, they
did not significantly affect dimerization when incubated
individually (Figure 9B and Figure 9C). When RNAs
from trans complementary mutant pairs SA057 + SA058
and SA059 + SA060 were incubated together to initiate
the intermolecular interactions owing to the transcomplementary nature of the substituted sequences,
these also showed dimerization to the wild type levels
(Figure 9B and Figure 9C). Taken together, these results
suggest that PBS pal is unlikely to be the primary point
of contact between the two gRNAs to augment efficient
MMTV dimerization. They also suggest that the effect
of the PBS pal deletion on RNA dimerization (mutant
SA051; Figure 3B, Figure 3C,) is indirect. Thus, in
agreement with earlier results, these observations argue
that pal II acts as the major point of contact, facilitating
MMTV gRNA dimerization.
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HIV-1 pal containing additional flanking purines, SA047,
restored dimerization to the wild type levels (Figure 5C).
Furthermore, substitution of pal II with trans complemen-
tary mutations significantly reduced RNA dimeriza-
tion when incubated individually (see SA044 + SA045 in
Figure 5C), further confirming the role of pal II in RNA
dimerization. However, contrary to our expectations,
when RNAs from these two trans complementary mu-
tants were incubated together, they failed to restore
dimerization (Figure 5C). This could in part be explained
by the lack of purine residues that have been shown to be
crucial for the stability of the RNA dimer [26]. There-
fore, we introduced two other substitution mutationsFigure 10 Further mutational analysis of pal II and pal III towards MM
(B) Typical RNA dimerization in TBM and TB gels of wild type and mutant MM
dimer conformer. (C) Quantification of the relative RNA dimerization levels (se
P values of the respective mutants in TBM and TB gels. The histograms represecontaining the exact sequences as in the pal II trans com-
plementary mutants, SA044 (5’ ACGCAC 3’) and SA045
(5’GUGCGU 3’) containing flanking purines (highlighted
in bold letters) not present in SA044 or SA045, resulting
in SA052 (5’ AAACGCACA 3’) and SA053 (5’AAGUGC
GUA 3’) (Figure 10A). As expected, in vitro dimerization
of these mutant RNAs was greatly affected when they were
incubated individually (P = 0.006 and 0.002 for SA052 and
SA053, respectively (Figure 10B and Figure 10C). On the
other hand, when these trans complementary mutant
RNAs were incubated together, the RNA dimerization
was restored to the wild type levels (SA052 + SA053 in
Figure 10B and Figure 10C). These results not only confirm
that pal II plays a major role in initiating intermolecularTV gRNA dimerization. (A) Description of the pal II and pal III mutants.
TV RNAs. M: monomer lane or monomer conformer; D: dimer lane or
e table below the histogram). Table above the histogram represent the
nt data from at least three independent experiments (± SD).
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importance of flanking purines in stabilizing RNA dimers
mediated by the HIV-1 pal [26].
Finally, structural analysis of the double deletion mu-
tant (SA046; pal II and PBS pal) predicted that this mu-
tant RNA could homodimerize via pal III (Figure 4D).
Since dimerization was found to be abrogated for this
mutant (Figure 3C), it is unlikely that these dimers are
being formed during MMTV replication. To test this
experimentally, we created a mutant in which pal III was
deleted (SA061; Figure 10A). Test of this mutant re-
vealed that deletion of pal III did not have any effect on
dimerization (Figure 10B and Figure 10C), suggesting
pal III has no role in MMTV RNA dimerization. Overall,
these results suggest that pal II is the primary RNA
dimerization determinant in MMTV.
Discussion
In an attempt to enhance our understanding of the gRNA
dimerization and packaging processes during MMTV life
cycle, we first validated the predicted structure of MMTV
packaging signal RNA employing SHAPE. The SHAPE-
validated structure was similar, but not identical to the
Mfold-predicted structure. An important feature revealed
by SHAPE was a U5/Gag LRI, which was also supported
by phylogeny and in silico RNA structure predictions
(Figure 1, Additional files 1 and 2). The U5/Gag LRI
anchors the overall structure of MMTV packaging signal
RNA and is consistent with an earlier report showing that
the MMTV packaging sequence extends into gag [10].
Similar LRIs exist in the packaging signal RNAs of a
number of retroviruses [21,23,56-59] and in several cases,
disruption of LRIs have been shown to affect RNA di-
merization and packaging [33,57,58]. In addition to LRI,
SHAPE validated the existence of the SL2 and SL4
domains. The SL2 domain contains the PBS and the pal I
sequence, and a similar large SL2 domain is found in
a number of other retroviral packaging signal RNAs
[8,21,23,56,60]. The bifurcated SL4 hairpin contains a pal
helix loop (pal II) and an ssPurines loop (Figure 1). Both
SL2 and SL4 structures are conserved in all the 8 MMTV
strains studied (Additional files 1 and 2).
The presence of a stretch of purines in the packaging
sequences on retroviral gRNA has been proposed to fa-
cilitate RNA packaging by functioning as a potential NC
binding site [11,26,61,62]. Thus, it is interesting to note
that the bifurcated SL4 domain contains a purine-rich
loop (5’ GGAGAAGAG 3’) adjacent to the pal II helix
loop (Figure 1), reminiscent to the situation found in
MPMV [8,21]. In the case of MPMV, genetic and
structure-prediction analyses have suggested that either
ssPurines or its partial repeat base-paired sequence in an
adjacent region plays a crucial role in gRNA packaging,
possibly by functioning as a NC binding site [8].Therefore, it will be interesting to investigate the role of
ssPurines in MMTV gRNA packaging.
Retroviral gRNA dimerization has been suggested as a
prerequisite for packaging into the budding virions
(reviewed in [1-6,63]). This process is usually initiated
by conserved palindromic sequences that initiate kissing
loop interactions [3,6,21,23,25,29-33,55-57,64,65]. Nucleo-
tide sequence and structural analyses of MMTV pack-
aging signal RNA initially revealed four pal sequences (pal
I, pal II, PBS pal, and pal III, Figure 1). Our mutational
analysis clearly indicates that neither pal I (Figure 2) nor
pal III (Figure 10) is involved in RNA dimerization and
packaging. Nevertheless, pal I mutants had significant
propagation defects (Figure 2), suggesting that mutations
close to the PBS might affect annealing of the primer
tRNA or initiation of reverse transcription itself. On the
other hand, initial mutational analysis suggested that both
pal II and PBS pal play a role in MMTV RNA dime-
rization (Figure 3 and Figure 5). Indeed, mutations in pal
II (SA042) as well as PBS pal (SA051) reduced RNA
dimerization by 2-3-folds, while deleting both pal II and
PBS pal (SA046) resulted in nearly a complete abrogation
of dimerization (Figure 3). However, additional PBS pal
mutants (Figure 9) showed that unlike PBS pal deletion
(mutant SA046; Figure 3B, 3C), substitutions in PBS pal
had no effect on RNA dimerization, even when the wild
type sequence was replaced by a non-palindromic se-
quence (mutants SA057, SA058, SA059 and SA060;
Figure 9). These results indicate that the PBS pal does not
mediate intermolecular interactions by direct base pairing
and strongly suggest that the effect of the PBS pal deletion
on RNA dimerization is indirect. Interestingly, deletion of
either pal II or the PBS pal had a pronounced effect on
RNA packaging (even though the effect of pal II deletion
was more dramatic on packaging; Figure 3), suggesting
that the MMTV Gag precursor initially recognizes an
RNA dimer with two points of contact.
A classical way of demonstrating the existence of any
intermolecular interaction between viral RNAs is by using
trans-complementary mutants [21,53-55,66]. Our initial
attempts to restore RNA dimerization using trans-com-
plementary pal II mutants were not successful (Figure 5).
This unexpected result could however be explained by
misfolding of one of the mutants (SA045; Figure 6B and
Figure 8B). These two mutants were predicted to form
heterodimer via the PBS pal rather than via their trans
complementary substituted sequences (Figure 8C). Pre-
vious work with HIV-1 that showed that purines flanking
the palindromic sequence can enhance the stability of the
RNA kissing-loop dimer [26] led us to design additional
trans-complementary mutants with such purines (Figure 10,
mutants SA052 and SA053). While dimerization of these
RNA mutants was severely affected when they were incu-
bated alone, they dimerized in trans to wild type levels,
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merization by direct base pairing between two genomic
RNA molecules. Along the same lines, results obtained
with mutant SA047 (in which pal II was replaced by the
HIV-1 pal with the flanking purines) displayed wild type
RNA dimerization levels; however, its RNA packaging and
propagation were abolished (Figure 5), suggesting that the
pal II hairpin could also be involved in RNA-protein inter-
actions during genome encapsidation, perhaps at the pri-
mary sequence level. The overall 3D structure of the
packaging domain would thus probably be important for
Gag binding. This could explain why deletion of 5’ UTR
sequences forming the basal part in the SHAPE-validated
structure of SL2 abrogated MMTV gRNA packaging and
propagation [10].
Conclusions
Results presented in this study validate the higher order
structural features of the MMTV packaging signal RNA
using the SHAPE methodology, which includes LRI in-
volving complementary sequences from U5 and the gag
(U5/Gag LRI), ssPurines, and four palindromic sequences
(Figure 1). Employing a combination of genetic, bio-
chemical, and structural prediction approaches, we further
show that the MMTV genome uses pal II as the primary
point of contact, by likely functioning as the DIS, to
initiate intermolecular interactions augmenting efficient
gRNA dimerization, and leading to its encapsidation in
the assembling virus particles (Figure 3 and Figure 4, and
Figure 10). SHAPE analyses of pal II mutants further sup-
port its role in MMTV gRNA dimerization (Figure 6).
These results are in agreement with earlier studies on
determinants of MMTV gRNA packaging, and further re-
veal important functional relationships between gRNA
dimerization and packaging processes, suggesting that
MMTV prefers a dimeric genome as a packaging substrate.
Methods
Structural analyses
The secondary structure of the 5’ region of the MMTV
gRNA containing either 120 nt of gag (432 nt of the 5’ end
from R) or 400 nt of gag (containing 712 nt of the 5’ end
from R) were predicted using the Mfold server [67,68]. The
SHAPE reactivity data of the first 432 nt region was applied
in RNAstructure software (version 5.3) [69] as constraints
to develop the final structural model. The Mfold-predicted
and SHAPE-validated structures were redrawn with the
XRNA software (http://rna.ucsc.edu/rnacenter/xrna/xrna.
html). MMTV nucleotide positions refer to HYBMTV a
molecular clone created by Shackleford and Varmus [70].
Phylogenetic analyses
Nucleotides 1-432 of the gRNA of different strains of
MMTV were aligned using Clustal Omega [71,72] and aconsensus or “conservation annotation” structure for these
strains was predicted using RNAalifold server [73,74].
The accession numbers for different MMTV strains
used for sequence alignment are AF228550.1 (mtv-1) [75],
L37517.1 (mtv-6) [76], AF033807.1 [77], M15122.1 (BR6)
[78], D16249.1 (JYG) [78], AF228551.1 (C3H/HeJ) [75],
X00018.1 (GR) [79] and AF228552.1 (C3H) [75].
Construction of plasmids
The 5’ end of MMTV gRNA corresponding to nt 1-712
was amplified by polymerase chain reaction (PCR) using
the MMTV sub-genomic transfer vector DA024 [45] as
the template and the sense (S) OTR 984 (5’ CCCAAGCT
TAATACGACTCACTATAGGGCAACAGTCCTAATAT
TCACG 3’) and the antisense (AS) OTR 985 (5’ AA
ACCCGGGTTCCCCTGGTCCCATAAG 3’) primers. These
primers include the T7 promoter sequence (in bold) at the
5’ end along with flanking restriction sites (HindIII and
XmaI/SmaI, shown in italics). The HindIII and XmaI sites
were utilized to introduce the MMTV sequence into a
pUC-based cloning vector (pIC19R) [80]. Introduction of
these sequences (from OTRs 984 and 985) resulted in the
addition of GGG and CCC complementary sequences at
the ends of the RNA which created base pairing potential;
however, folding of the 5’ end of the MMTV genome
containing these artificially-introduced complementary
sequences in Mfold did not predict base pairing among
these sequences nor alter the overall RNA secondary
structure of this region (data not shown). The sequence of
the resulting clone, SA035, was confirmed by sequencing.
SA035 (containing 400 nt of gag) was also used as the wild
type clone for in vitro gRNA dimerization assays.
A number of mutations, including deletions, sub-
stitutions and substitution containing heterologous trans-
complementary sequences, were introduced in pal I
(5’ GUCGGCCGAC 3’), pal II (5’ CUGCAG 3’), PBS pal
(5’ CAGCUGGCGCC 3’), and pal III (5’ CCUCUCAGA
GAGG 3’) through splice overlap extension (SOE) PCR as
described previously [8,21,33,81]. Briefly, in round one,
the MMTV sub-genomic vector DA024 was amplified in
two separate PCRs using S and AS primers generating
products having overlapping complementary sequences.
In round two, the products from round one PCRs, which
anneal via their overlapping complementary sequences,
were amplified using outer primers OTR 984 (S) and OTR
985 (AS), generating a final product containing the desired
mutation(s). The sequences of S and AS primers used to
introduce mutations are provided in Additional file 4,
along with the clone names and the necessary description.
Some mutations were also cloned in the MMTV subge-
nomic transfer vector, DA024, to study the effect of these
mutations on RNA packaging and propagation. All clones
were confirmed by sequencing. Further details of cloning
can be obtained from the authors upon request.
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After linearization with the SmaI restriction enzyme, the
wild type (SA035) or mutant (SA031-SA033, SA041-
SA045, SA046, SA047 and SA051) clones were tran-
scribed in vitro to generate the RNAs to be used in
dimerization assays, as previously described [82]. Follow-
ing DNase treatment, RNA extraction and purification,
the RNAs were concentrated using Amicon Ultra-4 10 K
devices (Millipore) and their concentration was deter-
mined using nanodrop (ThermoScientific), as described
previously [21]. Finally, the quality of the purified RNAs was
checked by denaturing polyacrylamide gel electrophoresis.
SHAPE methodology
SHAPE [46-48] was performed on in vitro transcribed
RNAs using benzoyl cyanide (BzCN) following the proto-
col described recently [21]. Briefly, RNAs were modified
in the dimer buffer (final concentrations: 50 mM sodium
cacodylate, (pH 7.5), 300 mM KCl and 5 mM MgCl2) in
the presence of 2 μg total yeast tRNA (Sigma Aldrich).
The dimer buffer was used for the SHAPE analysis to help
identify points of contact involved in the dimerization
process. The modified RNAs were reverse transcribed
using two sets of AS primers: OTRs 9, 10, 11 and 12 (5’
AACAGATTTGGCTTCTGCGG 3’; MMTV nt 614-633)
and OTRs 13, 14, 15 and 16 (5’ AGTTTCTGCCCTTTT
GAGCC 3’; MMTV nt 325-344), labelled with VIC, FAM,
NED, or PET, respectively. These two sets of primers en-
abled the revere transcription of the entire RNA sequence
except for a few nucleotides at the 3’ end due to primer
binding. The primer extension products were loaded onto
an Applied Biosystems 3130xl genetic analyzer and the
electropherograms were analysed with the SHAPEfinder
[49,83]. The SHAPE reactivities were determined and nor-
malized as described earlier [21,49]. The normalized
SHAPE reactivity data from at least 3-6 independent ex-
periments (submitted as Additional file 5) were used as
constraints to validate the RNA secondary structure of the
MMTV packaging signal with RNAstructure (version 5.3)
[69] and also to determine the effects of pal mutations on
the overall higher order structure.
In vitro dimerization assay
In vitro dimerization assays of wild type and mutant
MMTV RNAs were performed as described previously
[21,82]. Briefly, 300 nM RNAs were heated at 90°C and
incubated in ice for 2 min followed by a 37°C incubation
for 30 min in either the dimer (final concentrations:
50 mM sodium cacodylate, pH 7.5; 300 mM KCl; 5 mM
MgCl2) or monomer (final concentrations: 50 mM so-
dium cacodylate, pH 7.5; 40 mM KCl; 0.1 mM MgCl2)
buffer. The samples were divided equally and analysed
by electrophoresis in TBM (50 mM Tris base, 45 mM
boric acid, 0.1 mM MgCl2) and TB (50 mM Tris base,45 mM boric acid) ethidium bromide prestained agarose
gels at 4°C or 20°C, respectively. Density of the dimeric
and monomeric species was quantitated using Quantity
One software, and percentage of dimerization was calcu-
lated and expressed as dimerization relative to the wild
type for each mutant, as described previously [21]. For
the in vitro dimerization assay of trans complementary
mutants, equal amounts (150 nM) of in vitro transcribed
RNAs from both the mutants (for a total of 300 nM)
were incubated together before electrophoresis, as
described above.
In vivo genetic complementation assay
The in vivo genetic trans-complementation assay used
two expression plasmids, JA10 and MD.G, to provide the
structural and enzymatic genes from MMTV Gag/Pol and
vesicular stomatitis virus (VSV-G) envelope regions, re-
spectively [45,84]. A third plasmid (MMTV sub-genomic
transfer vector-DA024) containing minimum cis-acting
sequences required for RNA packaging, reverse transcrip-
tion, and integration, served as a source of the packageable
vector RNA [45]. Design and rationale of the MMTV 3-
plasmid genetic complementation assay developed earlier by
our group is schematically shown in Additional file 3 [45].
Briefly, the particles produced by JA10 and MD.G allow
packaging of the transfer vector RNA by virtue of the
presence of the conventional packaging signal (ψ) on the
MMTV transfer vector (DA024). The pal I, pal II, and
PBS pal mutations introduced into the T7 promoter-based
vector were further cloned into the MMTV sub-genomic
transfer vector, DA024, and tested in this assay to monitor
their effects on gRNA packaging and propagation.
Human embryonic kidney (HEK) 293T producer cells
were transfected using the calcium phosphate tran-
sfection protocol to produce virus particles containing
the wild type or mutated RNAs, as described pre-
viously [10,45]. The luciferase expression vector, pGL3
(Promega), was used as an internal control to measure
transfection efficiency, as described earlier [8-10,33].
Supernatants containing viral particles were collected
and spun down at 4000 rpm on a table top centrifuge
for 10 min. A portion of the supernatant was used to
infect the human cervical cancer cell line (HeLaT4)
to determine the transduction efficiency by selection
with medium containing 200 μg/ml of hygromycin B
(Hyclone). Cells transduced with virus particles contain-
ing the packageable transfer vector RNA express the
marker Hygr gene, resulting in colonies which are mea-
sured as colony forming units (CFU/ml). The CFU/ml
values were then normalized to the transfection effi-
ciency. The normalized propagation efficiencies were
then divided by the wild type values to represent the
propagation of the mutants relative to the wild type
(Relative CFU/ml).
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cDNA preparation
Cells from the transfected cultures were fractionated
into nuclear and cytoplasmic fractions as described
previously [9,85]. Cellular RNAs from the cytoplasmic
fractions and packaged viral RNA were isolated from
the pelleted viral particles using Trizol and Trizol LS
reagents, respectively (Invitrogen), as described earlier
[9,85]. The extracted RNAs were amplified for 30 cycles
by conventional PCR using vector-specific primers OTR
671(S) or and OTR 672 (AS) (Additional file 4) after
DNase (Promega) treatment to ensure that there was no
contaminating DNA present in the RNA samples. The
PCR conditions were as follows: denaturation for 2 min
at 94°C, followed by 30 cycles of 45 sec at 90°C, annea-
ling for 45 sec at 60°C and extension for 45 sec at 72°C
followed by incubation at 4°C. The DNase-treated cyto-
plasmic and viral RNA samples were reverse transcribed
into cDNA and PCR amplified to determine the quality
of the cDNA samples. To determine the integrity of the
nuclear membrane during cytoplasmic RNA extraction,
a multiplex PCR was performed on the cDNAs prepared
from the cytoplasmic RNA fractions using OTR 582 (S)
and OTR 581 (AS) (Additional file 4) designed to amp-
lify unspliced β-actin mRNA [9,85]. Amplifications of
the cDNAs using primers/competimer for 18S ribosomal
RNA (18S Quantum competimer control, Ambion) was
also performed as an ancillary control for the presence
of amplifiable cDNA in the multiplex PCRs [9,85].
Real time quantitative PCR (qPCR) for transfer vector RNA
packaging efficiency
To determine the packaging efficiency of the transfer vec-
tor RNA, quantitative qPCR was performed on the cDNA
prepared from the cytoplasmic and viral RNAs as de-
scribed earlier [10]. The endogenous control for qPCR
was β-actin (Human β-actin Endogenous Control assay,
VIC⁄MGB probe, Applied Biosystems). The primers and
probes for MMTV transfer vector RNAs in the FAM-
based Applied Biosystems custom expression assay anneal
at a 68 nt region in the MMTV U5 (nt 1192-1259) com-
mon to wild type and mutant RNAs. The relative amplifi-
cation efficiencies of the MMTV and β-actin expression
assays were determined to be 0.0126, thus, validating the
assays for quantitative PCR analysis using the ΔΔCt
method [10]. Equal amounts of viral and cytoplasmic
cDNA were tested in triplicates. The amplification condi-
tions used were as follows: Uracil-N-glycosylase incuba-
tion 2 min at 50°C, denaturation for 10 min at 95°C,
followed by 40 cycles of denaturation and annealing/
extension steps at 95°C for 15 sec and 60°C for 1 min. The
relative packaging efficiencies were derived following a
modification of our earlier described method [10]. Briefly,
the raw Ct (cycle threshold) values for the MMTVtransfer vector were normalized by the Ct values of the
β-actin endogenous control. The normalized values were
then calculated relative to the mock sample (relative quan-
tification, RQ) that was transfected with all the plasmids
except the transfer vector plasmid forming the empty
virus particles without any packaged RNA. For final rela-
tive packaging efficiency calculations, the relative viral RQ
values were divided by the relative cytoplasmic RQ values,
and the resulting values were normalized to the transfec-
tion efficiencies. The final values are presented relative to
the wild type.
Statistical analysis
The standard paired, two-tailed Student’s t-test was
performed between the wild type and mutant clones to
determine statistically significant differences. For in vitro
dimerization assays, and in vivo packaging and propaga-
tion studies, a p value of ≤0.05 was considered significant.Additional files
Additional file 1: Phylogenetic conservation of the sequences of
major structural motifs of MMTV packaging signal RNA in different
strains. (A) Clustal Omega sequence alignment of eight different strains
of MMTV packaging signal RNA. Sequences of the major structural motifs
are highlighted in different colors, whereas the 11 nt pal sequence within
PBS is boxed. The accession numbers for the MMTV strains are provided
in the Materials and Methods. (B) Sequence conservation superimposed
on the SHAPE validated structure. The nucleotides are color-coded based
on their conservation level, ranging from <75 to 100%.
Additional file 2: Consensus RNA secondary structure prediction of
MMTV packaging signal RNA using sequences from eight different
strains. Accession numbers of MMTV strains are the same as mentioned
in materials and methods section. The sequences of the 8 MMTV strains
were aligned using Clustal Omega and the aligned sequences were used
as input in the RNAalifold server [73,74] to predict the consensus or
“conservation annotation” structure. The number/color scale on the x-axis
indicates base pairing conservation with 1 (red color) representing
completely conserved base pairing to 6 (violet color) representing 6
different types of base pairings at that position among the various strains
(see Methods for details). The y-axis represents the incompatibility score
based on non-Watson base pairing within each strain. The number (0-2)
or color gradation (dark to very pale) represents increasing number of
strains showing incompatible (non-Watson) base pairing within the
structure of the various strains. Thus, a dark red color denotes “highest”
conservation of base pairings, while a light violet color represents “least”
conservation of base pairing among different strains of MMTVs.
Additional file 3: Schematic representation of the design and
rationale of three plasmid trans complementation assay for
studying MMTV gRNA packaging and propagation developed
earlier [45]. The pseudotyped particles produced following transfection
of human embryonic kidney (HEK) 293T cells with MMTV Gag/Pol
expression plasmid (JA10) and VSV-G envelope expression plasmid (MD.
G) allows packaging of the transfer vector RNA by virtue of the presence
of the packaging signal (ψ) on the MMTV transfer vector (DA024). Virus
particles produced following transfection contain the packaged transfer
vector RNA (DA024) and are used to quantitate RNA packaging by real
time PCR or to infect target cells to monitor RNA propagation.
Additional file 4: Table describing primers used for cloning,
sequencing, and conventional and real time PCR.
Additional file 5: Normalized SHAPE reactivity data from at least
three to six independent experiments.
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